R. Anderson is a Cardiology physician affiliated with University of Florida. OpenAlex indexes 233 publications with 7,643 citations (h-index 36). By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-273-9079Registry record last updated 18 Sept 2018.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202514 payments
- Boston Scientific CorporationProgram year20251 payment
- Shockwave Medical, IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
91.7%Adenosine Receptor Agonist59.2%Regadenoson100%Part B, office-administered≥123 patientsBeta blocker12%Metoprolol Succinate64%Metoprolol Tartrate20%Carvedilol16%Part D<11 patients+ 6 more classes in this area
Blood & clotting
6.6%Factor Xa inhibitor5.2%Eliquis100%Part D≥19 patientsP2Y12 inhibitor1.4%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
1.7%SGLT2 inhibitor1.7%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1985–1998 per NIH RePORTER. The latest:
- PATHOGENESIS OF GLAUCOMATOUS CUPPING--NO, O2 &PERICYTES
University of Miami School of Medicine
FY1996R01EY010465
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of the ABCD‐GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi‐Site, Real‐World Investigation
Clinical Pharmacology & Therapeutics
2022 - Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
New England Journal of Medicine
2021 - Incidence, Clinical Presentation, and Causes of 30-Day Readmission Following Hospitalization With Spontaneous Coronary Artery Dissection
JACC: Cardiovascular Interventions
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dekosky, MD
University of Florida
Brian Hoh, MD
University of Florida
Frederic Kaye, MD
University of Florida
Kelly Foote, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”